MX2014002630A - Produccion de alcaloides sin el aislamiento de compuestos intermediarios. - Google Patents

Produccion de alcaloides sin el aislamiento de compuestos intermediarios.

Info

Publication number
MX2014002630A
MX2014002630A MX2014002630A MX2014002630A MX2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A
Authority
MX
Mexico
Prior art keywords
alkaloids
intermediates
isolation
production
processes
Prior art date
Application number
MX2014002630A
Other languages
English (en)
Inventor
Tao Jiang
Peter X Wang
David W Berberich
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Publication of MX2014002630A publication Critical patent/MX2014002630A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a procesos para la producción de alcaloides sin el aislamiento de compuesto intermediarios.
MX2014002630A 2011-09-08 2012-09-07 Produccion de alcaloides sin el aislamiento de compuestos intermediarios. MX2014002630A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161532253P 2011-09-08 2011-09-08
PCT/US2012/054099 WO2013036729A1 (en) 2011-09-08 2012-09-07 Production of alkaloids without the isolation of intermediates

Publications (1)

Publication Number Publication Date
MX2014002630A true MX2014002630A (es) 2014-04-14

Family

ID=46982922

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014002630A MX2014002630A (es) 2011-09-08 2012-09-07 Produccion de alcaloides sin el aislamiento de compuestos intermediarios.

Country Status (14)

Country Link
US (1) US8624031B2 (es)
EP (1) EP2753622B1 (es)
JP (1) JP2014526467A (es)
KR (1) KR20140063763A (es)
CN (1) CN103917543A (es)
AU (1) AU2012304484B2 (es)
BR (1) BR112014005421A2 (es)
CA (1) CA2845187A1 (es)
ES (1) ES2566620T3 (es)
IL (1) IL231292A0 (es)
MX (1) MX2014002630A (es)
PL (1) PL2753622T3 (es)
RU (1) RU2014112493A (es)
WO (1) WO2013036729A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2718211T3 (es) 2013-05-24 2019-06-28 Rhodes Tech Compuestos cetales opioides y usos de los mismos

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE922827C (de) 1951-02-08 1955-01-27 Knoll Ag Verfahren zur Herstellung von quartaeren Ammoniumsalzen, die 2 Tetrahydroisochinolinreste enthalten
US2772270A (en) 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
DE1119284B (de) 1959-09-02 1961-12-14 Boehringer Sohn Ingelheim Verfahren zur Herstellung von antagonistisch gegen Morphin und schmerzstillend wirkenden quartaeren Salzen des Normorphins und deren acylierten Derivaten
FR1602610A (en) 1962-10-10 1971-01-04 10.10.62.-17.4.63. 38445-15209 thebaine derivs
US3438989A (en) 1967-03-10 1969-04-15 Warner Lambert Pharmaceutical Process for the production of ( ) dihydrothebainone
US3717643A (en) 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
FR2189403A1 (en) 1972-06-15 1974-01-25 Merck & Co Inc Norcodeine prepn - by reduction of 1-halo-norcodeinones, novel intermedi-ates for narcotic antagonists
US4089855A (en) 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
EP0034480A3 (en) 1980-02-14 1982-01-13 Grigg, Ronald Ernest Alkylation of amines
US4368326A (en) 1980-07-03 1983-01-11 Rice Kenner C Short total synthesis of dihydrothebainone, dihydrocodeinone, and nordihydroccodeinone
US4521601A (en) 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4795813A (en) 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US4443605A (en) 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
FR2562072B1 (fr) 1984-03-27 1989-07-07 Mallinckrodt Inc Procede de preparation de la noroxymorphone a partir de la morphine, et composes intermediaires utilises dans ce procede
HU197750B (en) 1984-07-17 1989-05-29 Alkaloida Vegyeszeti Gyar Process for n-demethylation of morphine alkaloids
US4775759A (en) 1984-11-27 1988-10-04 The United States Of America As Represented By The Department Of Health And Human Services Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US4673679A (en) 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5668285A (en) 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US4912114A (en) 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
US4991391A (en) 1989-01-27 1991-02-12 Westinghouse Electric Corp. System for cooling in a gas turbine
PT95069B (pt) 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
US5208338A (en) 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
CH683005A5 (it) 1991-10-30 1993-12-31 Aldo Massarotti Procedimento per la preparazione, mediante ossidazione di N-ossidi per le terapie dei tossicomani da oppiati.
NZ246687A (en) 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof
CN1111900A (zh) 1993-06-30 1995-11-15 东丽株式会社 止咳药
WO1995032973A1 (en) 1994-05-31 1995-12-07 Mallinckrodt Chemical, Inc. The preparation of nalbuphine having low levels of beta-epimer
CN1045442C (zh) 1994-07-20 1999-10-06 中国科学院上海药物研究所 左、右旋氯斯库利啉及它的制备方法和用途
EP1300381B1 (en) 1995-12-06 2006-03-08 Japan Science and Technology Agency Process for preparing optically active alcohols
DE19548399A1 (de) 1995-12-22 1997-06-26 Basf Ag Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen
GB9616253D0 (en) 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics
ATE263563T1 (de) 1996-11-25 2004-04-15 Toray Industries Mittel gegen juckreiz
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
JP2002503693A (ja) 1998-02-20 2002-02-05 アブマックス，インコーポレイティド エピモルフィン型化合物及びその使用
GB9821067D0 (en) 1998-09-29 1998-11-18 Zeneca Ltd Transfer hydrogenation process
WO2001014382A1 (fr) 1999-08-23 2001-03-01 Toray Industries, Inc. Analgesiques contenant des derives sel d'ammonium quaternaire comme principe actif
WO2001074819A1 (fr) 2000-04-03 2001-10-11 Toray Industries, Inc. Agents analgesiques contenant des derives de n-oxyde de morphinane en tant que principe actif
JP4024992B2 (ja) 2000-04-27 2007-12-19 オリバー ヤオ−プ フ ポリナルブフィン誘導体及びそれを製造するための方法
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
IL160193A0 (en) 2001-08-23 2004-07-25 Akzo Nobel Nv Process for the preparation of a 14-hydroxynormorphinone derivative
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
EP1562953B1 (en) 2002-11-08 2009-09-30 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
MXPA05009757A (es) 2003-03-13 2005-12-05 Controlled Chemicals Inc Conjugados de oxicodona con menor potencial de abuso y duracion de accion extendida.
CA2520030A1 (en) 2003-03-26 2004-10-07 Pharmacia & Upjohn Company Llc Process to produce enantiomerically enriched alcohols and amines
CA2539659C (en) 2003-09-22 2013-03-26 Johnson Matthey Public Limited Company Process for the synthesis of morphinane compounds and intermediates thereof
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
SK286047B6 (sk) 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6887999B1 (en) 2004-05-21 2005-05-03 Acura Pharmaceuticals, Inc. Preparation of dihydrocodeine from codeine
CA2574362A1 (en) 2004-07-23 2006-01-26 Pliva-Istrazivanje I Razvoj D.O.O. Process
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
MX2007005389A (es) 2004-11-05 2007-12-07 Rensselaer Polytech Inst 4-hidroxibenzomorfanos.
US9662390B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
KR101333620B1 (ko) 2005-04-06 2013-11-27 도레이 카부시키가이샤 모르피난 유도체의 결정 및 그 제조법
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
JP2009519960A (ja) 2005-12-15 2009-05-21 ナチュアメッド グループ コーポレーション シノメニン派生物の調合と使用
WO2007137785A2 (en) 2006-05-25 2007-12-06 Alpharma (Bermuda) Investments Ltd Process useful in the preparation of morphinan antagonists
RU2009112685A (ru) 2006-09-20 2010-10-27 Маллинкродт Инк. (Us) Получение замещенных морфинан-6-онов и их солей и промежуточных соединений
FR2906252B1 (fr) 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008064353A2 (en) 2006-11-22 2008-05-29 Progenics Pharmaceuticals, Inc. 7,8-saturated-4,5-epoxy-morphinanium analogs
BRPI0719587A2 (pt) 2006-11-22 2013-12-17 Progenics Pharm Inc (s)-n-estereoisômeros de análogos de 7,8-saturados-4,5-epóxi-morfinano
BRPI0719593A2 (pt) 2006-11-22 2013-12-17 Progenics Pharm Inc Processos para sintetizar os análogos de 4,5-epóxi-morfinano quaternário e isolar seus n-estereoisômeros
MX2009005461A (es) 2006-11-22 2009-08-28 Progenics Pharm Inc N-oxidos de analogos de 4,5-epoxi-morfinano.
EP2222642B1 (en) 2007-12-17 2014-02-12 Mallinckrodt LLC Process and compounds for the production of (+) opiates
NZ591756A (en) * 2008-09-16 2013-04-26 Mallinckrodt Llc Processes for the synthesis of five and six membered heterocyclic rings
ES2439015T3 (es) 2008-09-30 2014-01-21 Mallinckrodt Llc Procedimientos de aminación selectiva de cetomorfinanos
WO2010096788A1 (en) 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinanium quaternary salts and processes for their production

Also Published As

Publication number Publication date
PL2753622T3 (pl) 2016-07-29
WO2013036729A1 (en) 2013-03-14
JP2014526467A (ja) 2014-10-06
CN103917543A (zh) 2014-07-09
KR20140063763A (ko) 2014-05-27
IL231292A0 (en) 2014-04-30
CA2845187A1 (en) 2013-03-14
ES2566620T3 (es) 2016-04-14
EP2753622B1 (en) 2016-01-20
AU2012304484A1 (en) 2014-02-27
RU2014112493A (ru) 2015-10-20
US20130066080A1 (en) 2013-03-14
US8624031B2 (en) 2014-01-07
AU2012304484B2 (en) 2016-07-28
BR112014005421A2 (pt) 2017-04-04
EP2753622A1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
PL2744768T3 (pl) Sposób wytwarzania klinkieru zawierającego ternezyt
HRP20160692T1 (hr) Postupak za proizvodnju intermedijera estetrola
IN2014CN04160A (es)
MX2013015147A (es) Procesos y compuestos intermediarios para producir azaindoles.
GB201103836D0 (en) Conjugation process
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2012MU03723A (es)
ZA201308445B (en) Process for the production of estetrol intermediates
MX2013007567A (es) Procedimiento para preparar poliestereteroles.
IN2014DN09450A (es)
ZA201205844B (en) Process for the production of anhydrides
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
IN2013MU01113A (es)
IN2014DN09451A (es)
WO2014118606A3 (en) A novel process for the preparation of silodosin
IN2014DN10209A (es)
MX337610B (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
MX2014002630A (es) Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
WO2014170909A3 (en) Process for pomalidomide
IN2014DN07498A (es)
IN2014CN02645A (es)
IN2013MU01305A (es)
IN2014MU00069A (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal